Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up.


OBJECTIVES Poly-l-lactic acid (PLA) injections modestly increase objectively assessed facial thickness but not facial soft tissue volume (FSTV) over 24 weeks. The durability of this response has not been well defined objectively. METHODS HIV-infected lipoatrophic adults were randomized to four open-label PLA treatments administered every 2 weeks from week… (More)
DOI: 10.1111/j.1468-1293.2008.00667.x


6 Figures and Tables

Cite this paper

@article{Carey2009PolyllacticAF, title={Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up.}, author={Dianne L Carey and David Baker and Kathy Petoumenos and John Chuah and Gary D. Rogers and John E Watson and David A. Cooper and Sean Emery and Andrew Carr}, journal={HIV medicine}, year={2009}, volume={10 3}, pages={163-72} }